Learn About Congenital Mitral Stenosis

What is the definition of Congenital Mitral Stenosis?
Congenital mitral stenosis is when an infant is born with a narrowing of the opening of the mitral valve. The mitral valve is made of leaf-like flaps and is situated between the upper left chamber (atrium) and lower left chamber (ventricle) of the heart. Congenital mitral stenosis reduces the blood flow from the left atrium to the left ventricle. Individuals born with congenital mitral stenosis also often have other congenital heart defects.
Save information for later
Sign Up
What are the symptoms of Congenital Mitral Stenosis?
Symptoms of congenital mitral stenosis may include feeling tired upon exertion, chest pain, shortness of breath, coughing, rapid breathing, bluish or greyish color of skin, lips, and fingernails, trouble eating or gaining weight (failure to thrive), swelling of body tissue or organs, abnormal heart rhythms, such as palpitations or other arrhythmias, pulmonary hypertension (high blood pressure), fluid build-up in the lungs, and heart failure.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Congenital Mitral Stenosis?
Treatment for congenital mitral valve stenosis depends on its severity and may include diuretics to lessen fluid build-up in the lungs, blood thinners (anticoagulants), such as heparin, warfarin, aspirin, and fibrinolytics, such as tissue plasminogen activator (tPA), to prevent blood clots, drugs to control the heart rhythm (antiarrhythmics, beta blockers, and calcium channel blockers), and surgical repair or replacement of the mitral valve.
Who are the top Congenital Mitral Stenosis Local Doctors?
Learn about our expert tiers
Learn more
What are the latest Congenital Mitral Stenosis Clinical Trials?
The International Stress Echo Study to to Define the Future of Imaging

Summary: With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2- SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The International Stress Echo Study in Ischemic and Non-ischemic Heart Disease

Background: Stress echocardiography (SE) has an established role in evidence-based guidelines, but recently the breadth and variety of applications has extended well beyond coronary artery disease (CAD). Purpose: To establish a prospective research study of SE applications, in and beyond CAD, also considering a variety of signs in addition to regional wall motion abnormalities.

What are the Latest Advances for Congenital Mitral Stenosis?
Mid and long-term follow-up of 50 pediatric cardiac Chadians operated in France from 2003 to 2012.
Tired of the same old research?
Check Latest Advances